Kejin Wu

832 total citations
26 papers, 628 citations indexed

About

Kejin Wu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Kejin Wu has authored 26 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Kejin Wu's work include Cancer Risks and Factors (6 papers), Breast Cancer Treatment Studies (6 papers) and Breast Implant and Reconstruction (4 papers). Kejin Wu is often cited by papers focused on Cancer Risks and Factors (6 papers), Breast Cancer Treatment Studies (6 papers) and Breast Implant and Reconstruction (4 papers). Kejin Wu collaborates with scholars based in China, United States and Germany. Kejin Wu's co-authors include Yunshu Lu, Maoli Wang, Yijun Jia, Hongliang Chen, Mingjie Zhu, Fang Bai, Wei Feng Shen, Mingdi Zhang, Jian Chen and Qing Lin and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of the American College of Surgeons.

In The Last Decade

Kejin Wu

26 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kejin Wu China 13 223 200 162 100 63 26 628
Nancie Petrucelli United States 14 251 1.1× 355 1.8× 224 1.4× 53 0.5× 38 0.6× 24 1.3k
Susan B. Brown United States 8 322 1.4× 175 0.9× 337 2.1× 50 0.5× 128 2.0× 10 893
Xian Wen Sun China 12 372 1.7× 333 1.7× 103 0.6× 53 0.5× 42 0.7× 38 1.0k
Jorge Villanova Biazús Brazil 15 141 0.6× 48 0.2× 82 0.5× 115 1.1× 55 0.9× 27 536
J.L. Misset France 13 357 1.6× 121 0.6× 143 0.9× 43 0.4× 35 0.6× 39 733
Melissa H. Madden United States 15 86 0.4× 210 1.1× 121 0.7× 129 1.3× 41 0.7× 21 712
Yincheng Teng China 17 77 0.3× 222 1.1× 108 0.7× 56 0.6× 12 0.2× 55 922
Christopher Li United States 12 135 0.6× 219 1.1× 114 0.7× 33 0.3× 30 0.5× 27 635
Claire Mulot France 18 515 2.3× 306 1.5× 389 2.4× 81 0.8× 94 1.5× 43 1.1k
Danjie Jiang China 17 61 0.3× 419 2.1× 145 0.9× 61 0.6× 12 0.2× 47 761

Countries citing papers authored by Kejin Wu

Since Specialization
Citations

This map shows the geographic impact of Kejin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejin Wu more than expected).

Fields of papers citing papers by Kejin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejin Wu. The network helps show where Kejin Wu may publish in the future.

Co-authorship network of co-authors of Kejin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Kejin Wu. A scholar is included among the top collaborators of Kejin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejin Wu. Kejin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Yujin, et al.. (2024). Autonomous vehicle pollution monitoring: An innovative solution for policy and environmental management. Transportation Research Part D Transport and Environment. 139. 104542–104542. 4 indexed citations
2.
Wang, Maoli, et al.. (2022). Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer. Journal of Oncology. 2022. 1–14. 23 indexed citations
3.
Shi, Wenjie, Maoli Wang, Luz Angela Torres-de la Roche, et al.. (2022). An Innovative Breast-Conserving Oncoplastic Technique for Treating Small to Medium Volume Breasts With a Tumor in the Lower Quadrant: The Folding Flap Technique. Frontiers in Oncology. 12. 841682–841682. 2 indexed citations
4.
Chen, Jihui, Zhipeng Wang, Shouhong Gao, et al.. (2021). Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer. Cancer Cell International. 21(1). 183–183. 2 indexed citations
5.
Chen, Jihui, Zhipeng Wang, Shouhong Gao, et al.. (2021). Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer. Cancer Cell International. 21(1). 136–136. 25 indexed citations
6.
Chen, Yiyuan & Kejin Wu. (2021). [Status and clinical response of fertility preservation in young patients with breast cancer].. PubMed. 59(2). 104–108. 2 indexed citations
7.
Du, Jun-Xian, et al.. (2021). A retrospective clinical study of patients with pregnancy-associated breast cancer among multiple centers in China (CSBrS-008). Chinese Medical Journal. 134(18). 2186–2195. 5 indexed citations
8.
10.
Wang, Maoli, Kejin Wu, & Hongliang Chen. (2019). ASO Author Reflections: Oncotype DX RS Complementing the Prognostic Stage in the Updated AJCC 8th Edition for T1-2N1M0 ER-Positive HER2-Negative Breast Cancer. Annals of Surgical Oncology. 26(5). 1236–1237. 5 indexed citations
11.
Chen, Hongliang, Peng Zhang, Mingdi Zhang, et al.. (2019). Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer. Journal of Surgical Research. 239. 224–232. 11 indexed citations
12.
Bai, Fang, You Yin, Ting Chen, et al.. (2018). Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer. International Journal of Nanomedicine. Volume 13. 1327–1339. 22 indexed citations
13.
Fu, Shuangshuang, et al.. (2018). [Retrospective analysis of diagnosis and treatment of breast cancer in pregnancy].. PubMed. 56(2). 114–118. 2 indexed citations
15.
Lu, Yunshu, Yipeng Yang, Yan Liu, et al.. (2017). Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer. Biochemical and Biophysical Research Communications. 494(3-4). 719–727. 21 indexed citations
17.
Jia, Yijun, Lei Xu, Qing Lin, et al.. (2014). Levels of lymphocyte subsets in peripheral blood prior treatment are associated with aggressive breast cancer phenotypes or subtypes. Medical Oncology. 31(6). 981–981. 15 indexed citations
18.
Jia, Yijun, Yunshu Lu, Kejin Wu, et al.. (2013). Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiology. 37(3). 197–206. 135 indexed citations
19.
Wu, Kejin, Zhiwei Quan, Yichu Zhang, et al.. (2006). Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Research and Treatment. 101(3). 259–267. 51 indexed citations
20.
Wu, Kejin, Qinghua Tao, Gufa Lin, et al.. (2003). Stage-specific expression of breast cancer-specific gene gamma-synuclein.. PubMed. 12(9). 920–5. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026